PB2122: A PHASE 1/2 MULTI‐CENTER, DOSE‐FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN‐D5, A NOVEL BCL‐2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS

Saved in:

Bibliographic Details
Published in:	HemaSphere Vol. 7; no. S3; pp. e5544426 - n/a
Main Authors:	Kastritis, Efstathios, Matous, Jeffrey, Berdeja, Jesus, Abro, Emad, Augustson, Bradley, Perianes, Valentin Cabañas, Cibeira, M. Theresa, Cohen, Yael, Fong, Michael, Gatt, Moshe, DE LA Calle, Veronica Gonzalez, Kwok, Fiona, Lavi, Noa, Magen, Hila, Oriol, Albert, Palladini, Giovanni, Stockerl‐Goldstein, Keith, Eves, Taylor, Zheng, Cheng, Fiorino, Anthony
Format:	Journal Article
Language:	English
Published:	Philadelphia, PA Lippincott Williams & Wilkins 08-08-2023 Wiley
Subjects:	Publication Only
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	2572-9241 2572-9241
DOI:	10.1097/01.HS9.0000975252.55444.26